Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.01 USD | +2.56% | -2.67% | -44.58% |
Financials (USD)
Sales 2024 * | 42.96M | Sales 2025 * | 132M | Capitalization | 723M |
---|---|---|---|---|---|
Net income 2024 * | -397M | Net income 2025 * | -332M | EV / Sales 2024 * | 5.11 x |
Net cash position 2024 * | 503M | Net cash position 2025 * | 330M | EV / Sales 2025 * | 2.98 x |
P/E ratio 2024 * |
-1.84
x | P/E ratio 2025 * |
-2.3
x | Employees | 487 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.53% |
Latest transcript on Sage Therapeutics, Inc.
1 day | +2.56% | ||
1 week | -2.67% | ||
Current month | -13.85% | ||
1 month | -23.16% | ||
3 months | -48.39% | ||
6 months | -35.36% | ||
Current year | -44.58% |
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 14 M€ | -2.69% | ||
0.21% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 12.01 | +2.56% | 1,015,116 |
24-05-15 | 11.71 | -2.34% | 958,628 |
24-05-14 | 11.99 | -1.44% | 2,017,205 |
24-05-13 | 12.16 | +2.23% | 805,198 |
24-05-10 | 11.9 | -3.57% | 697,974 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.58% | 723M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.35% | 22.28B | |
-11.90% | 22.41B | |
-4.41% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- SAGE Stock